Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Aug 2017

Lynch Julie A, Berse Brygida, Dotson W David, Khoury Muin J, Coomer Nicole, Kautter John

Abstract excerpt

PURPOSE: We examined the utilization of precision medicine tests among Medicare beneficiaries through analysis of gene-specific tier 1 and 2 billing codes developed by the American Medical Association in 2012. METHODS: We conducted a retrospective cross-sectional study. The primary source of data was 2013 Medicare 100% fee-for-service claims. We identified claims billed for each laboratory test, the number of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Lung Neoplasms

Share to Precision Medicine

Share to United States

Source

Identifiers

PMID: 28125086
DOI: 10.1038/gim.2016.209

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data.PMID 28125086Read ↗

The landscape of pharmacogenetic testing in a US managed care populationSemantic proximity Read ↗

Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United StatesSemantic proximity Read ↗

Utilization of genetic testing: Analysis of 4,499 prior authorization requests for molecular genetic tests at four US regional health plansSemantic proximity Read ↗

Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?Semantic proximity Read ↗

Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing.Semantic proximity Read ↗

Medicare-funded cancer genetic tests: a note of caution.Semantic proximity Read ↗

Medical Policy Determinations for Pharmacogenetic Tests Among US Health PlansSemantic proximity Read ↗

A state-wide initiative to promote genetic testing in an underserved population.Semantic proximity Read ↗

Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.Semantic proximity Read ↗

Use of BRCA Mutation Test in the U.S., 2004-2014.Semantic proximity Read ↗

BRCA testing utilization among commercially insured women with breast or ovarian cancer.Semantic proximity Read ↗

Billing for Medical Genetics and Genetic Counseling Services: A National SurveySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.